Regulator says fee would enable it to quicken approval process.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances